Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

High Grade Glioma · Meningioma · Embryonal Tumor · Medulloblastoma · Anaplastic Ependymoma · Recurrent Diffuse Intrinsic Pontine Glioma · Recurrent Malignant Glioma · Recurrent Medulloblastoma · Recurrent Primary Central Nervous System Neoplasm · Refractory Diffuse Intrinsic Pontine Glioma · Refractory Malignant Glioma · Refractory Medulloblastoma · Refractory Primary Central Nervous System Neoplasm

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Children's Hospital Colorado, Aurora, Colorado, United States
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Contact: Study coordinator (Peter de Blank, MD) · Peter.deBlank@cchmc.org · 513-517-2068
Nationwide Children's Hospital, Columbus, Ohio, United States
Contact: Study coordinator (Margot Lazow, MD) · margot.lazow@nationwidechildrens.org
Contact: Study coordinator (Melinda Triplet) · melinda.triplet@nationwidechildrens.org · 614-722-6039
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Michael J Fisher) · fisherm@email.chop.edu · 12155905188

Study leads

Margot Lazow, MD
Principal Investigator
Nationwide Children's Hospital

View source on ClinicalTrials.gov Contact study team (email)